Physician

Herbert L Wang, MD

According to 2025 Medicare claims, Herbert Wang, MD (NPI: 1699746081) practices radiation oncology in the Tacoma-Lakewood, WA market, with the plurality of this provider's patient population coming from Pierce, WA. This provider's primary affiliated billing organization is TACOMA RADIATION ONCOLOGY CENTER INC, PS (NPI: 1255449146; TIN: 911465583) and primary practice location at 98405-5303.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 316 traditional Medicare patients, billed 3,654 HCPCS/CPT codes, and received $629,119 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 149 prescription claims across 66 beneficiaries totaling $1,370 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). 2022 DME data shows 11 claims. Open Payments data shows 15 records totaling $567. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $526,098 and ending at $629,119. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $46,208 to $1,370. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	297	3,171	$526,098
2016	306	2,679	$419,527
2017	362	3,486	$539,808
2018	301	2,766	$464,317
2019	245	3,264	$588,174
2020	151	2,385	$409,602
2021	272	2,797	$470,526
2022	264	2,377	$376,897
2023	284	3,074	$528,180
2024	316	3,654	$629,119

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	38	86	$46,208
2016	17	37	$6,303
2017	17	33	$617
2018	23	38	$1,939
2019	21	51	$1,582
2020	35	82	$2,064
2021	43	83	$2,150
2022	52	109	$1,769
2023	70	147	$1,553
2024	66	149	$1,370

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$122,316
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	85	723	$289
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	101	151	$94
77014	Ct guidance for insertion of radiation therapy fields	181	1,013	$89
77334	Design and construction of complex radiation treatment device	76	183	$83
77300	Calculation of radiation therapy dose	70	322	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	92	4,410	$770
Lorazepam	Lorazepam	11	111	$14

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$567	Monteris Medical Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Herbert L. Wang, MD?

Tedicare shows public-source Medicare data for Herbert L. Wang, MD (NPI 1699746081), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Herbert L. Wang, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Herbert L. Wang, MD?

Herbert L. Wang, MD is linked to TACOMA RADIATION ONCOLOGY CENTER INC, PS (billing NPI 1255449146) in the available physician profile data.

Does Herbert L. Wang, MD have Open Payments data?

Herbert L. Wang, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.